New biomarkers and genes for prediction of type 2 diabetes;Neue Biomarker und Gene in der Prädiktion des Typ-2-Diabetes

Diabetologe

Volumn 10, Issue 7, 2014, Pages 566-571

  Herder, C ^a,b   Illig, T ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Amino acids; Genetics; Genome wide association study; Lipids; Metabolomics

Indexed keywords

ACID; BIOLOGICAL MARKER; LIPID;

AGE DISTRIBUTION; ARTICLE; EPIGENETICS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LIFESTYLE; METABOLITE; METABOLOMICS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; PREDICTION; PREDICTIVE VALUE; PROTEOMICS; TRANSCRIPTOMICS;

EID: 85027940171     PISSN: 18609716     EISSN: 18609724     Source Type: Journal    
DOI: 10.1007/s11428-014-1211-y     Document Type: Article

References (31)

1. International Diabetes Federation (2013) IDF Diabetes Atlas, 6. Aufl. International Diabetes Federation, Brussels
2. Rathmann W, Scheidt-Nave C, Roden M et al (2013) Type 2 diabetes: prevalence and relevance of genetic and acquired factors for its prediction. Dtsch Arztebl Int 110:331–337
3. Schulze MB, Hoffmann K, Boeing H et al (2007) An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 30:510–515
4. Buijsse B, Simmons RK, Griffin SJ et al (2011) Risk assessment tools for identifying individuals at risk of developing type 2 diabetes. Epidemiol Rev 33:46–62
5. Herder C, Kowall B, Tabak AG et al (2014) The potential of novel biomarkers to improve risk prediction of type 2 diabetes. Diabetologia 57:16–29
6. Grarup N, Sandholt CH, Hansen T et al (2014) Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond. Diabetologia 57:1528–1541
7. Hivert MF, Vassy JL, Meigs JB (2014) Susceptibility to type 2 diabetes mellitus – from genes to prevention. Nat Rev Endocrinol 10:198–205
8. Walford GA, Porneala BC, Dauriz M et al (2014) Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care. DOI 10.2337/dc14-0560 1935-5548
9. Dimas AS, Lagou V, Barker A et al (2014) Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63:2158–2171
10. Morris AP, Voight BF, Teslovich TM et al (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990
11. Steinthorsdottir V, Thorleifsson G, Sulem P et al (2014) Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat Genet 46:294–298
12. Moltke I, Grarup N, Jorgensen ME et al (2014) A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes. Nature 512:190–193
13. Lohmueller KE, Sparso T, Li Q et al (2013) Whole-exome sequencing of 2,000 Danish individuals and the role of rare coding variants in type 2 diabetes. Am J Hum Genet 93:1072–1086
14. Mahajan A, Go MJ, Zhang W et al (2014) Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet 46:234–239
15. Vassy JL, Hivert MF, Porneala B et al (2014) Polygenic type 2 diabetes prediction at the limit of common variant detection. Diabetes 63:2172–2182
16. Klimentidis YC, Wineinger NE, Vazquez AI et al (2014) Multiple metabolic genetic risk scores and type 2 diabetes in three racial/ethnic groups. J Clin Endocrinol Metab jc20141818
17. Langenberg C, Sharp SJ, Franks PW et al (2014) Gene-lifestyle interaction and type 2 diabetes: the EPIC InterAct case-cohort study. PLoS Med 11:e1001647
18. Aschard H, Chen J, Cornelis MC et al (2012) Inclusion of gene-gene and gene-environment interactions unlikely to dramatically improve risk prediction for complex diseases. Am J Hum Genet 90:1–11
19. Bain JR, Stevens RD, Wenner BR et al (2009) Metabolomics applied to diabetes research: moving from information to knowledge. Diabetes 58:2429–2443
20. Fiehn O (2002) Metabolomics – the link between genotypes and phenotypes. Plant Mol Biol 48:155–171
21. Nicholson JK, Connelly J, Lindon JC et al (2002) Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 1:153–161
22. Illig T, Gieger C, Zhai G et al (2010) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42:137–141
23. Suhre K, Shin SY, Petersen AK et al (2011) Human metabolic individuality in biomedical and pharmaceutical research. Nature 477:54–60
24. Assfalg M, Bertini I, Colangiuli D et al (2008) Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci U S A 105:1420–1424
25. Psychogios N, Hau DD, Peng J et al (2011) The human serum metabolome. PLoS One 6:e16957
26. Spratlin JL, Serkova NJ, Eckhardt SG (2009) Clinical applications of metabolomics in oncology: a review. Clin Cancer Res 15:431–440
27. Suhre K, Meisinger C, Döring et al (2010) Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One 5:e13953
28. Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17:448–453
29. Würtz P, Soininen P, Kangas AJ et al (2013) Branched-chain and aromatic amino acids are predictors of insulin resistance in young adults. Diabetes Care 36:648–655
30. Wang-Sattler R, Yu Z, Herder C et al (2012) Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 8:615
31. Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62:639–648